Horikawa I, Oshimura M, Barrett J C
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
Mol Carcinog. 1998 Jun;22(2):65-72. doi: 10.1002/(sici)1098-2744(199806)22:2<65::aid-mc1>3.0.co;2-j.
The cellular senescence program is controlled by multiple genetic pathways, one of which involves the regulation of telomerase and telomere shortening. The introduction of a normal human chromosome 3 into the human renal cell carcinoma cell line RCC23 caused repression of telomerase activity, progressive shortening of telomeres, and restoration of the cellular senescence program. We attributed the repression of telomerase activity to the marked downregulation of the gene encoding the catalytic subunit of telomerase (hEST2/hTRT) but not another protein component (TP1/TLP1) or the RNA component of telomerase. These results suggest that a senescence-inducing gene on chromosome 3 controls hEST2/hTRT gene expression either directly or indirectly and support the notion that hEST2/hTRT is the major determinant of telomerase enzymatic activity in human cells.
细胞衰老程序受多种遗传途径控制,其中之一涉及端粒酶调节和端粒缩短。将一条正常人类3号染色体导入人肾癌细胞系RCC23导致端粒酶活性受到抑制、端粒逐渐缩短以及细胞衰老程序得以恢复。我们将端粒酶活性的抑制归因于编码端粒酶催化亚基的基因(hEST2/hTRT)的显著下调,而非另一种蛋白质组分(TP1/TLP1)或端粒酶的RNA组分。这些结果表明,3号染色体上的一个衰老诱导基因直接或间接控制hEST2/hTRT基因表达,并支持hEST2/hTRT是人类细胞中端粒酶酶活性主要决定因素的观点。